# Effect of iNO on Invasively Derived Pulmonary Pressures in Patients With PAH

> **NCT02734953** · PHASE2 · COMPLETED · sponsor: **Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)** · enrollment: 10 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** Nitric Oxide

## Key facts

- **NCT ID:** NCT02734953
- **Lead sponsor:** Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2016-08
- **Final completion:** 2016-12
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02734953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02734953, "Effect of iNO on Invasively Derived Pulmonary Pressures in Patients With PAH". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02734953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*